glutathione therapy for parkinson& 39 S-transferase: A keystone in Parkinson's disease pathogenesis and Parkinson's Disease: Current Treatment Modalities

Our quality control measures address the specific challenges of peptide manufacturing, including proper handling of the C-H bonds and molecular structures

367 A 7-week placebo-controlled trial in 80 elderly patients with subthreshold depression found acetyl-L-carnitine was as effective as the antidepressant fluoxetine for reducing symptoms, but symptomatic improvements were more rapid with acetyl-L-carnitine than fluoxetine

These findings underline the importance of the glutathione reductase for maintenance of the GSH/GSSG homeostasis, as recently reviewed in (Couto et al., 2016)

Pro-opiomelanocortin messenger RNA levels increase in the fetal sheep pituitary during late gestation

Mice null for ALDH1A1 and ALDH2 exhibit Parkinson's disease-like age-dependent deficits in motor performance and significant increase in biogenic aldehydes